Impact of catheter ablation for atrial fibrillation on cardiac ventricular electrical activity: assessment of premature ventricular complex burden - Scorecard - MDSpire

Impact of catheter ablation for atrial fibrillation on cardiac ventricular electrical activity: assessment of premature ventricular complex burden

  • By

  • Johannes Wörsdörfer

  • Noah Fantazi

  • Anas Alnaimi

  • Mostafa-Mahdi Emrani

  • Maximiliane Oldhafer

  • Andreas Napp

  • Nikolaus Marx

  • Matthias Daniel Zink

  • Michael Gramlich

  • March 30, 2026

  • 0 min

Share

Clinical Scorecard: Effects of Catheter Ablation on Ventricular Electrical Activity in Atrial Fibrillation Patients: Evaluation of Premature Ventricular Complex Frequency

At a Glance

CategoryDetail
ConditionAtrial fibrillation (AF), a common cardiac arrhythmia associated with stroke, heart failure, and dementia
Key MechanismsPulmonary vein isolation (PVI) via Cryoballoon (CRYO), Radiofrequency (RF), or Pulsed Field Ablation (PFA) to isolate arrhythmogenic foci
Target PopulationAdults with paroxysmal or persistent AF undergoing first-time PVI without additional ablations or major complications
Care SettingCardiology electrophysiology units performing catheter ablation procedures with follow-up ECG monitoring

Key Highlights

  • PVI is a first-line treatment for AF using CRYO, RF, or PFA energy sources with distinct mechanisms of tissue ablation
  • The study evaluates changes in premature ventricular complex (PVC) burden at 3 and 12 months post-PVI in a real-world cohort under standard antiarrhythmic therapy
  • Continuous ECG monitoring and standardized follow-up protocols enable assessment of ventricular electrical activity and arrhythmia recurrence

Guideline-Based Recommendations

Diagnosis

  • Confirm AF diagnosis with ECG prior to ablation
  • Classify AF as paroxysmal or persistent per 2024 ESC guidelines
  • Exclude left atrial appendage thrombus via transesophageal echocardiography before PVI

Management

  • Perform first-time PVI using CRYO, RF, or PFA according to institutional protocols
  • Ensure adequate anticoagulation and sedation during ablation
  • Adjust antiarrhythmic drug therapy based on symptom assessment and ECG findings during follow-up

Monitoring & Follow-up

  • Conduct pre-procedural 24-hour ECG and post-procedural 72-hour ECG monitoring at 3 and 12 months
  • Instruct patients to obtain ECG documentation if AF symptoms occur
  • Review ECGs by specialist nurses and physicians for PVC burden and arrhythmia recurrence

Risks

  • Exclude patients with major procedural complications such as cardiac tamponade or significant bleeding
  • Monitor for potential increases in PVC burden post-ablation
  • Consider procedural risks and patient-specific factors when selecting ablation modality

Patient & Prescribing Data

Patients with paroxysmal or persistent AF undergoing first-time PVI under standard-of-care antiarrhythmic drug therapy

Antiarrhythmic medications were maintained as per clinical indication; PVC burden changes were evaluated in this real-world treated cohort

Clinical Best Practices

  • Adhere to standardized institutional PVI protocols and ESC AF classification guidelines
  • Use continuous and extended ECG monitoring pre- and post-ablation to assess ventricular ectopy and arrhythmia recurrence
  • Select ablation energy source (CRYO, RF, PFA) based on patient characteristics and physician discretion
  • Exclude patients with additional ablation lesions or major complications to ensure homogeneity in outcome assessment
  • Apply rigorous statistical methods including non-parametric tests and correction for multiple comparisons in PVC burden analysis

References

Original Source(s)

Related Content